CCP
Clough Capital Partners Portfolio holdings
AUM
$997M
This Quarter Return
-0.27%
1 Year Return
+37.42%
3 Year Return
+130.83%
5 Year Return
+251.5%
10 Year Return
+1,002%
AUM
$1.31B
AUM Growth
+$1.31B
(-12%)
Cap. Flow
-$94.9M
Cap. Flow
% of AUM
-7.24%
Top 10 Holdings %
Top 10 Hldgs %
31.41%
Holding
150
New
39
Increased
28
Reduced
30
Closed
35
Top Buys
| 1 |
NVIDIA
NVDA
|
$31.8M |
| 2 |
Kinder Morgan
KMI
|
$30.3M |
| 3 |
Apple
AAPL
|
$29.8M |
| 4 |
Starwood Property Trust
STWD
|
$29.2M |
| 5 |
Exxon Mobil
XOM
|
$28.9M |
Top Sells
| 1 |
PennyMac Financial
PFSI
|
$79.8M |
| 2 |
Fidelity National Financial
FNF
|
$57.3M |
| 3 |
Micron Technology
MU
|
$54.5M |
| 4 |
Tesla
TSLA
|
$50M |
| 5 |
Amazon
AMZN
|
$39.2M |
Sector Composition
| 1 | Healthcare | 27% |
| 2 | Technology | 19.79% |
| 3 | Consumer Discretionary | 12.02% |
| 4 | Industrials | 9.34% |
| 5 | Financials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Lumentum
LITE
$9.37B
| $8.76M | 0.66% |
+89,700
| New | +$8.76M |
|
52
C4 Therapeutics
CCCC
$182M
| $8.64M | 0.66% |
356,181
+100,500
| +39% | +$2.44M |
|
53
Walker & Dunlop
WD
$2.79B
| $8.41M | 0.64% |
65,010
-25,720
| -28% | -$3.33M |
|
54
Intuitive Surgical
ISRG
$158B
| $8.33M | 0.63% |
+27,610
| New | +$8.33M |
|
55
HCA Healthcare
HCA
$95.4B
| $7.87M | 0.6% |
31,420
-4,850
| -13% | -$1.22M |
|
56
Kymera Therapeutics
KYMR
$3.1B
| $7.86M | 0.6% |
185,700
-85,300
| -31% | -$3.61M |
|
57
Apellis Pharmaceuticals
APLS
$3.51B
| $7.24M | 0.55% |
142,409
+10,660
| +8% | +$542K |
|
58
Zoetis
ZTS
$67.6B
| $7.11M | 0.54% |
37,681
| – | – |
|
59
Stryker
SYK
$149B
| $6.68M | 0.51% |
+25,000
| New | +$6.68M |
|
60
Abbott
ABT
$230B
| $5.45M | 0.41% |
+46,000
| New | +$5.45M |
|
61
Thermo Fisher Scientific
TMO
$183B
| $5.41M | 0.41% |
9,167
-6,450
| -41% | -$3.81M |
|
62
Legend Biotech
LEGN
$6.64B
| $4.71M | 0.36% |
129,691
-65,361
| -34% | -$2.38M |
|
63
Barings BDC
BBDC
$987M
| $4.59M | 0.35% |
443,826
-356,090
| -45% | -$3.68M |
|
|
HIE
64
DELISTED
Miller/Howard High Income Equity Fund
HIE
| $4.54M | 0.34% |
406,604
+78,900
| +24% | +$881K |
|
65
Hertz
HTZ
$1.68B
| $4.44M | 0.34% |
200,500
+1,600
| +0.8% | +$35.4K |
|
|
MRTX
66
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.35M | 0.33% |
52,902
-47,553
| -47% | -$3.91M |
|
67
iRhythm Technologies
IRTC
$5.67B
| $4.2M | 0.32% |
26,695
-68,680
| -72% | -$10.8M |
|
68
Veracyte
VCYT
$2.41B
| $4.07M | 0.31% |
147,670
-35,990
| -20% | -$992K |
|
|
BRW
69
Saba Capital Income & Opportunities Fund
BRW
$351M
| $4.07M | 0.31% |
450,065
+170,971
| +61% | +$1.55M |
|
70
Boston Scientific
BSX
$159B
| $3.91M | 0.3% |
+88,200
| New | +$3.91M |
|
|
CMPI
71
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
| $3.63M | 0.28% |
1,137,764
-168,862
| -13% | -$539K |
|
72
Cisco
CSCO
$268B
| $3.55M | 0.27% |
63,700
| – | – |
|
73
Eli Lilly
LLY
$661B
| $3.44M | 0.26% |
12,013
| – | – |
|
74
McKesson
MCK
$85.9B
| $3.44M | 0.26% |
11,232
-62,088
| -85% | -$19M |
|
|
FTF
75
Franklin Limited Duration Income Trust
FTF
$259M
| $3.44M | 0.26% |
+453,195
| New | +$3.44M |
|